Neuralink Seeks Participants in Human Trials

Neuralink's first human trials aim to unlock the potential of thought-controlled technology for individuals with paralysis.

Screen Shot 2022 04 18 At 2 41 24 Pm
Getty Images

Elon Musk's Neuralink is preparing for its first human trials, called the "PRIME Study," to assess its brain-computer interface implant's safety and functionality. According to the Interesting Engineering article, the company is seeking participants with quadriplegia or ALS to test the implant's ability to enable thought-controlled external devices. The N1 implant will be placed in the brain's movement control area with the help of the R1 Robot. The goal is to see if individuals can operate a computer with thought alone. Musk believes his technology can restore full body movement.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO